Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $66.3200 (-0.63%) ($66.3200 - $66.3200) on Mon. Aug. 7, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.05% (three month average) | RSI | 38 | Latest Price | $66.3200(-0.63%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.2% a day on average for past five trading days. | Weekly Trend | LGND declines -0.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) XBI(47%) IBB(46%) XHB(44%) UNG(38%) XAR(33%) | Factors Impacting LGND price | LGND will decline at least -1.025% in a week (0% probabilities). UUP(-25%) TBT(-24%) VXX(-18%) XLU(-13%) URA(-13%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.025% (StdDev 2.05%) | Hourly BBV | -0.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $64.32(-3.02%) | Resistance Level | $67.45 | 5 Day Moving Average | $66.48(-0.24%) | 10 Day Moving Average | $66.9(-0.87%) | 20 Day Moving Average | $67.45(-1.68%) | To recent high | -16.7% | To recent low | 0.2% | Market Cap | $1.066b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |